Estée Lauder
Up to $5,000
Claims opening soon
Multiple class actions related to opioid use are ongoing in Canada, with a $29.3 million settlement approved against Purdue Canada, Valeant, and Mylan.
Class actions alleging harm from the overprescription of opioid medications and seeking recovery of healthcare costs.
Class actions concerning opioid use are continuing across Canada. In Ontario, a $29.3 million settlement was approved against Purdue Canada, Valeant, and Mylan in the case Gebien v Apotex Inc. The court found the settlement reasonable and approved a distribution protocol designed to provide accessible claims while prioritizing those most affected. In British Columbia, the Court of Appeal upheld the certification of a class action brought by the province against pharmaceutical manufacturers, wholesalers, and distributors to recover healthcare costs related to opioid overprescription.
Compensation pending
Claim deadline: Pending court decision
Estée Lauder
Up to $5,000
Claims opening soon
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
613 days left

Meta (Facebook)
Up to $90
Claims opening soon
Ticketmaster
Compensation pending
Claims opening soon
Apple
Up to $100
Claims opening soon